Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
130.00    -0.90 (-0.69%)
Bid:
129.50
Ask:
129.90
Spread: 0.40 (0.309%)
Market Cap: £328.76m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Board Appointment

29 Apr 2021 07:00

RNS Number : 9923W
Marshalls PLC
29 April 2021
 

29 April 2021

 

Marshalls plc

(the "Company" or "Marshalls")

 

Board Appointment

 

Justin Lockwood appointed as CFO

 

Marshalls plc, the specialist landscape products group, is pleased to announce the appointment of Justin Lockwood to the Board as Chief Financial Officer.

 

Justin is currently the Chief Financial Officer of International Personal Finance plc. He joined them in 2010 and held a number of senior finance roles prior to his appointment as CFO in 2017. Justin brings extensive experience of all aspects of financial management in large publicly listed companies.

 

Prior to International Personal Finance plc, Justin worked for Associated British Ports for four years in a senior finance role. His first role in industry was with Marshalls, between 2002 and 2006, where he worked in a variety of business unit and head office roles, including as finance director of Marshalls Clay Products before its disposal to Hanson plc. Justin is a chartered accountant, having qualified with PwC where he spent the first 10 years of his career.

 

Justin succeeds Jack Clarke who stepped down from the Board, and as Group Finance Director, on 31 March 2021. His appointment will take effect at a date to be agreed once his departure date from International Personal Finance plc has been finalised.

 

Martyn Coffey, CEO of Marshalls commented:

 

"We're delighted that Justin is joining the business. His rich, cross-sector experience, which includes time with Marshalls earlier in his career, will be an asset to the Board and help us capitalise on future growth opportunities and deliver our strategic objectives. In Justin, we're confident we've found an outstanding successor to Jack Clarke, who made a significant contribution to the sustained growth of Marshalls during his time with us."

 

Justin Lockwood commented:

 

"Marshalls is an exceptional business with strong heritage and a clear strategic vision. I'm delighted to be joining and look forward to working with Martyn, the Board and all of Marshalls' very dedicated colleagues"

 

There are no disclosures required pursuant to Listing Rule 9.6.13.

 

- Ends -

 

The information communicated in this announcement is inside information.

 

Enquiries:

 

Martyn Coffey, Chief Executive

Marshalls plc

+44 (0)1422 314777

Shiv Sibal, Company Secretary

Marshalls plc

+44 (0)1422 314767

Andrew Jaques

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVARAWUSUUR
Date   Source Headline
4th Dec 20188:49 amRNSIssue of Sharesave Shares and Total Voting Rights
3rd Dec 20184:09 pmRNSDirector/PDMR Shareholding
3rd Dec 20184:08 pmRNSDirector/PDMR Shareholding
30th Nov 20185:26 pmRNSHolding(s) in Company
28th Nov 20187:54 amRNSDirector Declaration - Amendment
28th Nov 20187:15 amRNSDirector Declaration
26th Nov 20189:32 amRNSBlock Listing
16th Nov 20182:03 pmRNSHolding(s) in Company
7th Nov 20185:34 pmRNSHolding(s) in Company
5th Nov 20183:16 pmRNSDirector/PDMR Shareholding
5th Nov 20183:12 pmRNSDirector/PDMR Shareholding
1st Nov 20183:41 pmRNSHolding(s) in Company
4th Oct 201810:11 amRNSDirector/PDMR Shareholding
4th Oct 201810:10 amRNSDirector/PDMR Shareholding
4th Sep 201810:11 amRNSDirector/PDMR Shareholding
4th Sep 201810:08 amRNSDirector/PDMR Shareholding
30th Aug 201812:57 pmRNSDirector/PDMR Shareholding
16th Aug 20187:00 amRNSHalf-year Report
9th Aug 20189:54 amRNSHolding(s) in Company
6th Aug 201811:39 amRNSDirector/PDMR Shareholding
3rd Aug 20183:37 pmRNSHolding(s) in Company
10th Jul 20183:50 pmRNSHolding(s) in Company
5th Jul 20189:05 amRNSDirector/PDMR Shareholding
5th Jul 20188:55 amRNSDirector/PDMR Shareholding
29th Jun 201810:27 amRNSDirector/PDMR Shareholding
28th Jun 20181:22 pmRNSDirector/PDMR Shareholding
5th Jun 20183:11 pmRNSDirector/PDMR Shareholding
5th Jun 20183:10 pmRNSDirector/PDMR Shareholding
31st May 20184:15 pmRNSDirectorate Change
10th May 20187:00 amRNSDirectorate Change
9th May 20182:49 pmRNSResult of AGM
9th May 20187:00 amRNSTrading Statement
4th May 20184:12 pmRNSDirector/PDMR Shareholding
4th May 20184:09 pmRNSDirector/PDMR Shareholding
20th Apr 201812:59 pmRNSDirectorate Change
20th Apr 20187:00 amRNSDirectorate Change
5th Apr 20185:51 pmRNSAnnual Financial Report
4th Apr 20189:27 amRNSDirector/PDMR Shareholding
4th Apr 20189:25 amRNSDirector/PDMR Shareholding
28th Mar 20185:22 pmRNSAnnual Financial Report
20th Mar 20184:55 pmRNSDirector/PDMR Shareholding
20th Mar 201811:35 amRNSDirector/PDMR Shareholding
20th Mar 201811:02 amRNSDirector/PDMR Shareholding
20th Mar 201810:45 amRNSDirector/PDMR Shareholding
14th Mar 20187:00 amRNSAnnual Financial Report
6th Mar 201810:07 amRNSDirector/PDMR Shareholding
6th Mar 20188:52 amRNSDirector/PDMR Shareholding
9th Feb 201812:20 pmRNSDirector Declaration
6th Feb 20184:32 pmRNSDirector/PDMR Shareholding
6th Feb 20184:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.